The biotech scorecard for Q1: 19 stock-moving events to watch

Get ready for readouts on Abbvie's cystic fibrosis treatment, Gilead's newly acquired cancer drug Trodelvy, and much more.

Related Keywords

Washington ,United States , ,Happy New ,Vertex Pharma ,Wall Street ,Silicon Valley ,